Aurora Spine was issued Patent No: 11,331,199, Spinal Implant for Motion Preservation or Fusion. This patent covers Aurora’s ZIPFlex™ Technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.
This new patent covers interlaminar motion-preserving and fusion implants in one device that could treat lumbar spinal degenerative diseases, such as spinal stenosis.
A ZIPFlex Technology-based implant could be implanted as a motion preservation device and months or years later could be converted from motion preservation device to a fusion implant via a minor keyhole procedure by adding a blocker element at the center of the main body.
Patented features of ZIPFlex include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant. Aurora’s ZIPFlex is reportedly the first technology to offer an all-in-one approach to providing viable options for treating patients with back pain.
Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, said, “As our IP portfolio continues to grow, so does the positive impact we can make for our physician customers and their patients. With this latest patent grant from the USPTO, we have further strengthened our value proposition and the depth and breadth of our portfolio of minimally invasive interlaminar devices.”
Aurora Spine was issued Patent No: 11,331,199, Spinal Implant for Motion Preservation or Fusion. This patent covers Aurora's ZIPFlex™ Technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.
This...
Aurora Spine was issued Patent No: 11,331,199, Spinal Implant for Motion Preservation or Fusion. This patent covers Aurora’s ZIPFlex™ Technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.
This new patent covers interlaminar motion-preserving and fusion implants in one device that could treat lumbar spinal degenerative diseases, such as spinal stenosis.
A ZIPFlex Technology-based implant could be implanted as a motion preservation device and months or years later could be converted from motion preservation device to a fusion implant via a minor keyhole procedure by adding a blocker element at the center of the main body.
Patented features of ZIPFlex include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant. Aurora’s ZIPFlex is reportedly the first technology to offer an all-in-one approach to providing viable options for treating patients with back pain.
Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, said, “As our IP portfolio continues to grow, so does the positive impact we can make for our physician customers and their patients. With this latest patent grant from the USPTO, we have further strengthened our value proposition and the depth and breadth of our portfolio of minimally invasive interlaminar devices.”
Copy to clipboard 
